Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 May;52(5):343–346. doi: 10.1136/ard.52.5.343

Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis.

H Franck 1, E Keck 1
PMCID: PMC1005047  PMID: 8323382

Abstract

OBJECTIVES--Osteocalcin is the major non-collagenous protein of bone and is regarded as a specific index of bone formation. The aim of this study was to examine the rate of bone formation measured by osteocalcin in 38 patients with ankylosing spondylitis (AS) and its dependence on various parameters of calcium and phosphate metabolism. METHODS--Serum osteocalcin, alkaline phosphatase, parathyroid hormone, and 1,25-dihydroxyvitamin D were measured in 38 patients with ankylosing spondylitis and in 52 controls. RESULTS--Mean serum osteocalcin was significantly reduced in patients with AS (men 1.7 (1.1) ng/ml; women 1.2 (1.1) ng/ml) compared with the corresponding control groups (men 3.2 (1.3) ng/ml; women 4.1 (1.7) ng/ml). In contrast, alkaline phosphatase was only slightly but significantly higher (135 (44) U/l) in patients with AS than in the corresponding controls (114 (35) U/l). Serum parathyroid hormone (AS 3.1 (0.7) v 2.7 (0.6) mE/ml) and 1,25-dihydroxyvitamin D (AS 64.0 (34.5) v 52.4 (6.7) pg/ml) were slightly but not significantly higher in patients with AS. Consequently, as both hormones are known to stimulate osteocalcin synthesis, they are not responsible for low osteocalcin levels in patients with AS. No significant correlation between alkaline phosphatase and osteocalcin was found. Low serum levels of osteocalcin in patients with AS reflect lower osteoblastic activity in AS. CONCLUSIONS--Bone turnover in patients with AS is characterised by low bone formation in the presence of normal levels of calcium regulating hormones.

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coen G., Mazzaferro S., Bonucci E., Taggi F., Ballanti P., Bianchi A. R., Donato G., Massimetti C., Smacchi A., Cinotti G. A. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up. Kidney Int. 1985 Nov;28(5):783–790. doi: 10.1038/ki.1985.198. [DOI] [PubMed] [Google Scholar]
  2. Deftos L. J., Parthemore J. G., Price P. A. Changes in plasma bone GLA protein during treatment of bone disease. Calcif Tissue Int. 1982 Mar;34(2):121–124. doi: 10.1007/BF02411221. [DOI] [PubMed] [Google Scholar]
  3. Franck H., van Valen F., Keck E., Krüskemper H. L. Osteocalcin und Knochenstoffwechsel bei rheumatoider Arthritis und Osteoarthrose. Z Rheumatol. 1986 Sep-Oct;45(5):241–246. [PubMed] [Google Scholar]
  4. Hanson C. A., Shagrin J. W., Duncan H. Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop Relat Res. 1971 Jan;74:59–64. [PubMed] [Google Scholar]
  5. Keck E., Krüskemper H. L., von Lilienfeld-Toal H. Protein binding assays for 25-hydroxy, 24,25-dihydroxy and 1,25-dihydroxy metabolites of vitamin D1) in human plasma. J Clin Chem Clin Biochem. 1981 Oct;19(10):1043–1050. doi: 10.1515/cclm.1981.19.10.1043. [DOI] [PubMed] [Google Scholar]
  6. Kendall M. J., Lawrence D. S., Shuttleworth G. R., Whitfield A. G. Haematology and biochemistry of ankylosing spondylitis. Br Med J. 1973 Apr 28;2(5860):235–237. doi: 10.1136/bmj.2.5860.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lukert B. P., Higgins J. C., Stoskopf M. M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab. 1986 May;62(5):1056–1058. doi: 10.1210/jcem-62-5-1056. [DOI] [PubMed] [Google Scholar]
  8. Price P. A., Nishimoto S. K. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2234–2238. doi: 10.1073/pnas.77.4.2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ralston S. H., Urquhart G. D., Brzeski M., Sturrock R. D. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ. 1990 Mar 3;300(6724):563–565. doi: 10.1136/bmj.300.6724.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Reid D. M., Nicoll J. J., Kennedy N. S., Smith M. A., Tothill P., Nuki G. Bone mass in ankylosing spondylitis. J Rheumatol. 1986 Oct;13(5):932–935. [PubMed] [Google Scholar]
  11. Will R., Palmer R., Bhalla A. K., Ring F., Calin A. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet. 1989 Dec 23;2(8678-8679):1483–1485. doi: 10.1016/s0140-6736(89)92932-2. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES